Literature DB >> 24037551

Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy.

Leticia Leon1, Lydia Abasolo, Loreto Carmona, Luis Rodriguez-Rodriguez, Jose Ramon Lamas, Cesar Hernandez-Garcia, Juan Angel Jover.   

Abstract

OBJECTIVE: To analyze sociodemographic and clinic-related factors associated with the use of orthopedic surgical procedures in rheumatoid arthritis (RA), focusing on the potential role of new biologic therapies.
METHODS: A retrospective medical record review was performed in a probability sample of 1272 patients with RA from 47 units distributed in 19 Spanish regions. Sociodemographic and clinical features, use of drugs, and arthritis-related joint surgeries were recorded following a standardized protocol.
RESULTS: A total of 94 patients (7.4%) underwent any orthopedic surgery during their disease course, with a total of 114 surgeries; 47 (41.2%) of these surgeries were total joint replacement (TJR). The median time to first orthopedic procedure was 7.9 years from the onset of RA symptoms, and the rate of orthopedic surgery (excluding TJR) was 4.5 procedures per 100 person-years from the beginning of RA, while the rate of TJR was 2.25 interventions per 100 person-years. A higher risk of undergoing an orthopedic surgical procedure was associated with taking nonsteroidal antiinflammatory drugs (NSAID) in the previous 2 years, female sex, longterm disease, and the presence of extraarticular complications. The risk factors for undergoing a TJR were being old, having a longterm disease, and taking biologic therapies.
CONCLUSION: In the era of biologics, our national audit found a low percentage of patients who underwent orthopedic surgery, probably reflecting a thorough management of the RA. Sociodemographic factors, longterm RA, extraarticular complications, and NSAID were associated with orthopedic surgery.

Entities:  

Keywords:  BIOLOGIC THERAPY; ORTHOPEDICS; RHEUMATOID ARTHRITIS

Mesh:

Substances:

Year:  2013        PMID: 24037551     DOI: 10.3899/jrheum.130118

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Synthetic disease-modifying antirheumatic drug prescribing variability in rheumatoid arthritis: a multilevel analysis of a cross-sectional national study.

Authors:  Iván Ferraz-Amaro; Daniel Seoane-Mato; Fernando Sánchez-Alonso; María A Martín-Martínez
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

Review 2.  Managing rheumatic and musculoskeletal diseases - past, present and future.

Authors:  Gerd R Burmester; Johannes W J Bijlsma; Maurizio Cutolo; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2017-06-15       Impact factor: 20.543

Review 3.  Altering the natural history of rheumatoid arthritis: The role of immunotherapy and biologics in orthopaedic care.

Authors:  Steven J Girdler; Ivan Ye; Ray Tang; Noah Kirschner
Journal:  J Orthop       Date:  2019-07-01

4.  Orthopedic Surgery Among Patients With Rheumatoid Arthritis: A Population-Based Study to Identify Risk Factors, Sex Differences, and Time Trends.

Authors:  Michael D Richter; Cynthia S Crowson; Eric L Matteson; Ashima Makol
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-09-07       Impact factor: 4.794

5.  Joint Surgery in Tunisian Rheumatoid Arthritis Patients: Prevalence and Risk Factors.

Authors:  Olfa Saidane; Leila Gafsi; Aicha Ben Tekaya; Ines Mahmoud; Rawdha Tekaya; Leila Abdelmoula
Journal:  Arch Rheumatol       Date:  2019-12-02       Impact factor: 1.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.